Tamir Sholklapper

Einstein Healthcare Network, Georgetown University

Papers

2

Total Citations

7

H-Index

2

About

Dr. Tamir Sholklapper is a urologic oncologist whose research focuses on optimizing treatment strategies for prostate cancer, particularly through the integration of advanced radiation techniques and the management of post-surgical complications. His major contributions include pioneering work on combining intensity-modulated radiation therapy (IMRT) with stereotactic body radiation therapy (SBRT) as a less-invasive boost for unfavorable prostate cancer, demonstrating promising five-year outcomes that challenge traditional brachytherapy approaches. This work, cited 5 times, highlights his commitment to improving biochemical relapse-free survival while reducing procedural invasiveness. Additionally, Dr. Sholklapper has contributed to the surgical literature by documenting rare but critical complications, such as a complex space of Retzius lymphocele causing iliac compression and pulmonary embolism after robotic Retzius-sparing prostatectomy—a case that underscores his attention to patient safety and clinical nuance. With a growing citation impact, his research bridges radiation oncology and urologic surgery, offering practical insights for clinicians. His achievements reflect a dedication to advancing personalized, less-invasive cancer care and enhancing our understanding of post-treatment morbidity.

Research Focus

Key Achievements

2
H-Index
2
Papers
7
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes
5 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Einstein Healthcare Network, Georgetown University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago